Literature DB >> 29784170

Effect of topical dorzolamide therapy on cystoid macular edema in hydroxychloroquine retinopathy.

Dong Geun Kim1, Chang Ki Yoon1, Hyun Woong Kim2, Sang Joon Lee3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29784170     DOI： 10.1016/j.jcjo.2017.10.022

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN： 0008-4182            Impact factor:   1.882


× No keyword cloud information.
  4 in total

Review 1.  Cystoid macular oedema without leakage in fluorescein angiography: a literature review.

Authors:  Masood Naseripour; Sara Hemmati; Samira Chaibakhsh; Arzhang Gordiz; Leila Miri; Fatemeh Abdi
Journal:  Eye (Lond)       Date:  2022-09-10       Impact factor: 4.456

Review 2.  Intravitreal dexamethasone implant therapy for the treatment of cystoid macular Oedema due to hydroxychloroquine retinopathy: a case report and literature review.

Authors:  Seong Joon Ahn; Jooyoung Joung; Sang Hyup Lee; Byung Ro Lee
Journal:  BMC Ophthalmol       Date:  2018-12-06       Impact factor: 2.209

3.  Combination of Intravitreal Bevacizumab and Topical Dorzolamide versus Intravitreal Bevacizumab Alone for Diabetic Macular Edema: A Randomized Contralateral Clinical Trial.

Authors:  Farhad Fazel; Hossein Nikpour; Mohsen Pourazizi
Journal:  Biomed Res Int       Date:  2020-01-16       Impact factor: 3.411

4.  Docetaxel-induced maculopathy possibly potentiated by concurrent hydroxychloroquine use.

Authors:  Abdelrahman M Elhusseiny; Nidhi Relhan; William E Smiddy
Journal:  Am J Ophthalmol Case Rep       Date:  2019-09-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.